Connection

Gary Gilkeson to Cytokines

This is a "connection" page, showing publications Gary Gilkeson has written about Cytokines.
Connection Strength

0.488
  1. Effects of bacterial DNA on cytokine production by (NZB/NZW)F1 mice. J Immunol. 1998 Oct 15; 161(8):3890-5.
    View in: PubMed
    Score: 0.117
  2. Differential efficacy of human mesenchymal stem cells based on source of origin. J Immunol. 2014 Nov 01; 193(9):4381-90.
    View in: PubMed
    Score: 0.088
  3. Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clin Immunol. 2012 Jul; 144(1):1-12.
    View in: PubMed
    Score: 0.074
  4. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther. 2011; 13(6):250.
    View in: PubMed
    Score: 0.073
  5. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol. 2004 Nov 15; 173(10):6481-9.
    View in: PubMed
    Score: 0.044
  6. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB ? NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells. Arthritis Rheumatol. 2021 08; 73(8):1478-1488.
    View in: PubMed
    Score: 0.035
  7. Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease. Lupus. 2018 Oct; 27(12):1898-1902.
    View in: PubMed
    Score: 0.029
  8. Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function. Stem Cell Res Ther. 2017 08 30; 8(1):192.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.